Company / Capital Returned to Shareholders
Opus Genetics, Inc. Capital Returned to Shareholders History
FY2011-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$28.4K
FY2013
5-year range
-
FY2011-FY2013
Trend
-
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$28,410 in FY2013.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2013 | $28.4K | - |
| FY2011 | $0 | - |
As of FY2013 · SEC 10-K · Updated Jun 24, 2026